Cannabis Rescheduling Reaches Its Final Stage: Post-Hearing Briefs Due August 17

What Happened

According to U.S. Drug Enforcement Administration (administrative record) on July 16, 2026 in Federal — DEA, The DEA’s formal hearing on rescheduling marijuana from Schedule I to Schedule III concluded on July 15, 2026 after 11 days of testimony. Chief Administrative Law Judge Derek Julius set an August 17 deadline for post-hearing briefs and closing arguments. After that, the ALJ will issue his recommendation to the DEA Administrator, who holds final decision authority. The primary source is linked in the Source section below; readers are encouraged to review it directly for full context.

Why This Is Trending Now

The August 17 brief deadline is the last procedural milestone before the ALJ’s recommendation, and from there the timeline for final DEA action is no longer fixed.

Why Businesses Should Pay Attention

Schedule III is not legalization. Its primary practical effect would be to remove the application of Section 280E for state-licensed operators, improve research access, and soften the federal regulatory posture. State licensing regimes remain the operating framework. The briefs filed by August 17 will shape the record the ALJ uses to recommend final action.

Practical Considerations

Businesses may want to monitor the status of the underlying rule, filing, proceeding, or announcement as it evolves. Companies may need to evaluate how this development could interact with current contracts, licenses, disclosures, and compliance programs. The issue may raise questions around vendor obligations, reporting timelines, and internal policy updates that warrant discussion with qualified counsel.

Cogent Law Perspective

Cogent Law advises cannabis operators on regulatory strategy, corporate structure, and compliance. We help clients model Section 280E relief scenarios, review structures built around 280E workarounds, and prepare for a Schedule III transition. The best next step is to speak with counsel about the facts specific to your organization.

Key Takeaways

• The August 17 brief deadline is the last procedural milestone before the ALJ’s recommendation, and from there the timeline for final DEA action is no longer fixed.
• Schedule III is not legalization. Its primary practical effect would be to remove the application of Section 280E for state-licensed operators, improve research access, and soften the federal regulatory posture. State licensing regimes remain the operating framework. The briefs filed by August 17 will shape the record the ALJ uses to recommend final action.
• Cogent Law advises cannabis operators on regulatory strategy, corporate structure, and compliance. We help clients model Section 280E relief scenarios, review structures built around 280E workarounds, and prepare for a Schedule III transition.
• Review the primary source from U.S. Drug Enforcement Administration (administrative record) for the full record before making any decisions.
• Speak with Cogent Law to discuss how this development may affect your business.

Related Practice Areas